Clinical Trials Browser

Terminated × lanreotide × Clear all

NCT05364944 2025-11-17

OXTEND-01

Phase 1 Terminated

EndocrineGastrointestinalNET

Gastro-enteropancreatic neuroendocrine tumor, Acromegaly

NCT02859064 2023-12-05

Study of Lanreotide in Patients With Metastatic Gastrointestinal Neuroendocrine Tumors Who Are Undergoing Liver-directed Radioembolization With Yttrium-90 Microspheres

Phase 2 Terminated

6 enrolled 12 charts

EndocrineGastrointestinalNET

Carcinoid Tumor, Gastrointestinal Neoplasms, Neuroendocrine Tumors

NCT02288377 2023-01-18

REMINET

Phase 2/3 Terminated

53 enrolled 11 charts

Neoplasm Metastasis

NCT02683941 2022-07-06

SPINET

Phase 3 Terminated

77 enrolled 20 charts

Neuroendocrine Tumors in Lung

NCT01861717 2021-09-30

A Pilot Study of Pre- and Post-operative Use of Somatuline Depot.

Phase 4 Terminated

4 enrolled 5 charts

Acromegaly, Gigantism, Pituitary Neoplasms

NCT01313273 2019-11-22

POSEIDON

Phase 3 Terminated

3 enrolled 4 charts

Prostatic Neoplasms